Yang JC, Xu P, Ning S, Wasielewski LJ, et al. Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer. Oncogene 2023 Jan 3. doi: 10.1038/s41388-022-02566.
PMID: 36596844